Info@nextgenpptides.com
0 Items
nextgenpptides.com
  • Home
  • Shop
    • Weefselherstel — IGF-1
    • Vetverbranding — AMPK
    • Cellulaire Veroudering — SIRT1
    • Endocriene Regulatie — GnRH
    • Neuroplasticiteit — BDNF
    • Bundeldeal Peptides
    • Onderzoeksbenodigheden
    • Spierhypertrofie — MSTN
  • Checkout
  • Cart
Select Page
Home / Cellulaire Veroudering — SIRT1

Cellulaire Veroudering — SIRT1

Showing 1–9 of 16 results

  • AHK-Cu 100 mg kopen in Nederland

    AHK-Cu 100mg

  • Sale! Anti-Aging Peptide Cream kopen in Nederland

    Anti-Aging Peptide Cream with GHK-Cu & Snap-8

    $54.00 – $148.00Price range: $54.00 through $148.00
  • ARA-290 10 mg kopen in Nederland

    ARA-290 10mg

  • Sale! BPC-157 10 mg kopen in Nederland

    BPC-157 10mg

    $85.00 – $153.00Price range: $85.00 through $153.00
  • Epithalon 10 mg kopen in Nederland

    Epithalon 10mg

  • Sale! GHK-Cu 50 mg kopen in Nederland

    GHK-CU 50mg

    $66.00 – $218.00Price range: $66.00 through $218.00
  • Sale! GHK-Cu 50 mg Pen kopen in Nederland

    GHK-Cu 50mg Pen

    $99.00 – $398.00Price range: $99.00 through $398.00
  • GHK-Cu Serum kopen in Nederland

    GHK-Cu Serum

  • Glow 70 mg Blend kopen in Nederland

    Glow 70 mg Blend

  • 1
  • 2
  • →

Recent Posts

  • Hello world!

Recent Comments

  1. A WordPress Commenter on Hello world!
Designed by Next Gen peptides | Powered by Next Gen Peptides All products available on this website are intended exclusively for research and development purposes. The products are in no way intended for human or animal consumption. The statements on this website have not been evaluated by the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA). The products offered by NextGenPeptides are not intended to diagnose, treat, cure, or prevent any disease. NEXTGEN Peptides is a supplier of research chemicals. NextGenPeptides is not a pharmacy, compounding pharmacy, or chemical compounding facility as defined under Section 503A of the U.S. Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility under Section 503B.